The US Department of Justice is scrutinising payments by leading pharmaceuticals companies for hospitality, consultants, licensing agreements and charitable donations in markets around the world as part of a wide-ranging corruption probe.
- Enjoy this article? Help vote it up the 'Vine.
- Public Discussion (1)
So now it's corruption instead of normal and usualbusiness practices....The DOJ needs to investigate Congress....
- 2 votes
You're in Easy Mode. If you prefer, you can use XHTML Mode instead. |
As a new user, you may notice a few temporary content restrictions. Click here for more info.



